Supply of Proprietary Leica Bond III In-Situ Hybridization (ISH) Reagents
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract involves the supply of proprietary reagents specifically designed for In-Situ Hybridization (ISH) testing on the Leica Bond III platform, focusing on molecular pathology applications. The reagents include probes, pretreatment solutions, and detection chemistries tailored for diagnostics in oncology and infectious diseases. The agreement is structured as a subcontract under the NAICS code 325414, which pertains to pharmaceutical preparation manufacturing. The contract was posted on May 27, 2026, and is managed by the Department of Veterans Affairs through the 248-NETWORK Contract Office 8 (36C248). Although specific location details for performance and contact information are not provided, the contract emphasizes proprietary material provision to support advanced diagnostic testing on the Leica Bond III instrument, enhancing molecular pathology capabilities within healthcare settings serving veterans.
General Info
Agency
NAICS
Place of Performance
FLSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
